Results 81 to 90 of about 429,194 (230)

Imaging of Central Nervous System Tumors

open access: yesActa Medica Alanya, 2018
Many Central Nerve System (CNS) tumors and even non–tumoral lesions may show a very similar imaging appearance; therefore, routine Magnetic Resonance Imaging (MRI) are lack of specificity to differentiate these lesions. The key points in the differential
Alptekin Tosun, İsmail Şerifoğlu
doaj   +1 more source

Commentary on Ferumoxytol and Beyond: Navigating the Shift Away From GBCAs in Neuro‐Oncology

open access: yes
Journal of Magnetic Resonance Imaging, EarlyView.
Vera C. Keil, Yelda Özsunar
wiley   +1 more source

Applications and prospects of artificial intelligence and digital medicine in pediatric nasal skull base tumors

open access: yesPediatric Investigation, EarlyView.
Pediatric nasal skull base tumors present diagnostic and therapeutic challenges due to their deep location, nonspecific symptoms, and the narrow nasal cavity in children. Although artificial intelligence (AI) and digital medicine have advanced early diagnosis, multidisciplinary treatment, and prognosis, their application in these rare tumors remains ...
Xiuping Wu   +5 more
wiley   +1 more source

Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study

open access: yesBiology Open, 2018
Non-invasive quantitation of liver disease using multiparametric magnetic resonance imaging (MRI) could refine clinical care pathways, trial design and preclinical drug development.
Anna M. Hoy   +12 more
doaj   +1 more source

Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This review systematically summarizes a full spectrum of non‐invasive diagnostic approaches for portal hypertension (PH), including imaging modalities, elastography, serum biomarkers, composite scoring systems and endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG), and analyzes their performance across different liver disease etiologies ...
Lijia Yin, Huikuan Chu, Ling Yang
wiley   +1 more source

Rare prostate cancer mimic on multiparametric MRI: Cowper's gland hyperplasia

open access: yes, 2021
Multiparametric MRI and targeted biopsies of the prostate have been increasingly utilized in men with elevated PSA. It is important to recognize potential mimics of prostate cancer on MRI and on biopsy specimens.
Liwei Jia   +3 more
core   +1 more source

Natural History of PI‐RADS 3 Lesions on Serial Prostate mpMRI

open access: yesThe Prostate, EarlyView.
ABSTRACT Objective PI‐RADS 3 lesions on prostate multiparametric MRI (mpMRI) are indeterminate findings with debated management. We evaluated their radiologic evolution on follow‐up mpMRI and correlated imaging changes with biopsy outcomes. Methods We retrospectively identified 166 men with at least one PI‐RADS 3 lesion on initial mpMRI and at least ...
Tomer Bashi   +13 more
wiley   +1 more source

Performance of multiparametric MRI appears better when measured in patients who undergo radical prostatectomy

open access: yes, 2018
Nancy N Wang,1 Richard E Fan,1 John T Leppert,1,2 Pejman Ghanouni,3 Christian A Kunder,4 James D Brooks,1 Benjamin I Chung,1 Geoffrey A Sonn1,3 1Department of Urology, Stanford University School of Medicine, Stanford, CA, USA; 2Veterans Affairs, Palo ...
Sonn GA   +7 more
core  

Precision Imaging for Prostate Cancer Localization: How Multiparametric Ultrasound Stands Against Multiparametric MRI [PDF]

open access: yes
Multiparametric MRI (mpMRI) is currently the standard imaging modality for the diagnosis of prostate cancer; however, studies have reported that targeted biopsy based on mpMRI may miss approximately 30% of clinically significant cases. Recent advances in
Amr Mohammed, MD, Priscilla Machado, MD, Tania Siu Xiao, MD, Aylin Tahmasebi, MD, Mostafa Alnoury, MD, Edouard Trabulsi, MD, Ethan J. Halpern, MD, John R. Eisenbrey, PhD, Flemming Forsberg, PhD
core   +3 more sources

Prognostic Value of MRI‐Derived Apparent Diffusion Coefficient in Intermediate‐Risk Prostate Cancer Treated With Definitive Radiotherapy

open access: yesThe Prostate, EarlyView.
ABSTRACT Background Intermediate‐risk prostate cancer (IR‐PCa) is a heterogeneous disease with variable clinical outcomes despite established risk classification. We evaluated whether pretreatment tumor apparent diffusion coefficient (ADC) derived from multiparametric MRI was associated with long‐term outcomes and provided additional prognostic ...
Cem Onal   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy